학술논문
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
Document Type
Article
Author
Moghadasi, S.; Janssen, L.A.M.; Van Asperen, C.J.; Meeks, H.D.; Vreeswijk, M.P.G.; Devilee, P.; Borg, Å.; Ehrencrona, H.; Paulsson-Karlsson, Y.; Wappenschmidt, B.; Engel, C.; Gehrig, A.; Arnold, N.; Van Overeem Hansen, T.; Ejlertsen, B.; Gerdes, A.-M.; Thomassen, M.; Kruse, T.A.; Jensen, U.B.; Pedersen, I.S.; Caputo, S.M.; Couch, F.; Hallberg, E.J.; Van Den Ouweland, A.M.W.; Collée, M.J.; Teugels, E.; Adank, M.A.; Van Der Luijt, R.B.; Mensenkamp, A.R.; Oosterwijk, J.C.; Blok, M.J.; García, E.G.; Janin, N.; Claes, K.B.M.; Tucker, K.; Viassolo, V.; Toland, A.E.; Eccles, D.E.; Spurdle, A.B.; Goldgar, D.E.
Source
In: Journal of Medical Genetics . (Journal of Medical Genetics, January 2018, 55(1):15-20)
Subject
Language
English
ISSN
14686244
00222593
00222593